A carregar...
Reimbursement recommendations for cancer drugs supported by phase II evidence in Canada
BACKGROUND: Phase ii data are increasingly being used as primary evidence for public reimbursement for oncologic drugs. We compared the frequency of reimbursement recommendations for phase ii and phase iii submissions and assessed for variables associated with a positive or conditional recommendatio...
Na minha lista:
| Publicado no: | Curr Oncol |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Multimed Inc.
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7606040/ https://ncbi.nlm.nih.gov/pubmed/33173389 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3747/co.27.6489 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|